Literature DB >> 8763487

Long-term isoprenaline administration and its effect on the revascularisation and regeneration of skeletal muscle transplants in mice.

P Roberts1, J K McGeachie.   

Abstract

The long-term administration of the beta 2-agonist isoprenaline (at 2 dosages: 100 micrograms/kg or 300 micrograms/kg) was investigated for its effect on the revascularisation and regeneration of skeletal muscle transplants in mice, and also to determine if there was a dose dependent effect. Morphometric, histological and autoradiographic techniques were employed for the investigation. It was found that the accelerated revascularisation observed in a previous short-term study on the effects of isoprenaline did not occur in longer-term usage (as evidenced by autoradiographic and histological results). However, in the present study, the numbers of presumptive satellite cells (identified by autoradiographic examination) were increased at both dosages in the isoprenaline-treated mice. Significant differences were seen in a number of the parameters examined morphometrically, both between the 2 groups which received isoprenaline, and between these groups and the controls (particularly in the volume of regenerated muscle). Dose dependency was therefore evident between the 2 isoprenaline doses and it was concluded that the increased volume of regenerated muscle seen in these transplants was due to the hypertrophic effect of isoprenaline.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763487      PMCID: PMC1167498     

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  16 in total

1.  The effect of a growth promoting drug, clenbuterol, on fibre frequency and area in hind limb muscles from young male rats.

Authors:  C A Maltin; M I Delday; P J Reeds
Journal:  Biosci Rep       Date:  1986-03       Impact factor: 3.840

2.  Long-term isoprenaline administration produces an increase in capillarity in the soleus muscle of the rat.

Authors:  A H Sillau; M de L Philippi
Journal:  Can J Physiol Pharmacol       Date:  1987-03       Impact factor: 2.273

Review 3.  Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase.

Authors:  T K Harden
Journal:  Pharmacol Rev       Date:  1983-03       Impact factor: 25.468

4.  The enhancement of revascularisation of skeletal muscle transplants using the beta 2-agonist isoprenaline.

Authors:  P Roberts; J K McGeachie
Journal:  J Anat       Date:  1994-04       Impact factor: 2.610

Review 5.  Receptor-specific mechanisms of desensitization of beta-adrenergic receptor function.

Authors:  C Hertel; J P Perkins
Journal:  Mol Cell Endocrinol       Date:  1984-10       Impact factor: 4.102

6.  Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol.

Authors:  N J Rothwell; M J Stock; D K Sudera
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

7.  Effect of handling and forced immobilization on rat plasma levels of epinephrine, norepinephrine, and dopamine-beta-hydroxylase.

Authors:  R Kvetnansky; C L Sun; C R Lake; N Thoa; T Torda; I J Kopin
Journal:  Endocrinology       Date:  1978-11       Impact factor: 4.736

8.  Block staining with p-phenylenediamine for light microscope autoradiography.

Authors:  R Dilley; J McGeachie
Journal:  J Histochem Cytochem       Date:  1983-08       Impact factor: 2.479

9.  Protein synthesis, amino acid uptake, and pools during isoproterenol-induced hypertrophy of the rat heart and tibialis muscle.

Authors:  Y Deshaies; J Willemot; J Leblanc
Journal:  Can J Physiol Pharmacol       Date:  1981-02       Impact factor: 2.273

10.  Mitosis and the processes of differentiation of myogenic cells in vitro.

Authors:  R Bischoff; H Holtzer
Journal:  J Cell Biol       Date:  1969-04       Impact factor: 10.539

View more
  2 in total

Review 1.  Developmental programming in response to intrauterine growth restriction impairs myoblast function and skeletal muscle metabolism.

Authors:  D T Yates; A R Macko; M Nearing; X Chen; R P Rhoads; S W Limesand
Journal:  J Pregnancy       Date:  2012-07-31

2.  Identification of the shared gene signatures and pathways between sarcopenia and type 2 diabetes mellitus.

Authors:  Shiyuan Huang; Chunhua Xiang; Yi Song
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.